Cargando…

Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era

Objectives: To evaluate long-term outcomes and late toxicities of nasopharyngeal carcinoma (NPC) patients with T1-2N0-3M0 stage in intensity-modulated radiotherapy (IMRT) era. Materials and Methods: From June 2005 to October 2013, 276 patients confirmed T1-2N0-3M0 NPC treated with IMRT were reviewed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Xiaoshuang, Xue, Fen, Liu, Peiyao, Hu, Chaosu, He, Xiayun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795811/ https://www.ncbi.nlm.nih.gov/pubmed/35165512 http://dx.doi.org/10.7150/ijms.68394

Ejemplares similares

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
por: Niu, Xiaoshuang, et al.
Publicado: (2021)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Long-term Patterns of Regional Failure for Nasopharyngeal Carcinoma following Intensity-Modulated Radiation Therapy
por: Xue, Fen, et al.
Publicado: (2017)

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3–4 nasopharyngeal carcinoma
por: Xue, Fen, et al.
Publicado: (2017)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2018)

Comparing Long-Term Survival and Late Toxicities of Different Sequential Chemotherapy Regimens with Intensity-Modulated Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Wu, Mingyao, et al.
Publicado: (2020)

Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wu, Mingyao, et al.
Publicado: (2018)

Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
por: Xue, Fen, et al.
Publicado: (2016)

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue
por: Niu, Xiaoshuang, et al.
Publicado: (2013)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Impact of Paranasal Sinus Invasion on Oncologic and Dosimetric Outcomes in Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy—Implications for Risk Stratification and Planning Optimization
por: Zhou, Xin, et al.
Publicado: (2020)

Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Liang, Zhong-Guo, et al.
Publicado: (2016)

Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland？
por: Niu, Xiaoshuang, et al.
Publicado: (2023)

Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma
por: He, Xiayun, et al.
Publicado: (2014)

Pre-treatment Serum Lactate Dehydrogenase is Predictive of Survival in Patients with Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

The Value of Cervical Node Features in Predicting Long-Term Survival of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era
por: Tian, Yun-Ming, et al.
Publicado: (2021)

Prognostic value of nutritional markers in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy: a propensity score matching study
por: Oei, Ronald Wihal, et al.
Publicado: (2018)

Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review
por: Wu, Peng, et al.
Publicado: (2020)

The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT
por: Xu, Tingting, et al.
Publicado: (2016)

Progression-Free Survival Prediction in Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy: Machine Learning vs. Traditional Statistics
por: Oei, Ronald Wihal, et al.
Publicado: (2021)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
por: Lyu, Yingchen, et al.
Publicado: (2020)

Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma
por: Kong, Fangfang, et al.
Publicado: (2014)

Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with chemoradiotherapy for induction chemotherapy resistant locally advanced nasopharyngeal carcinoma: A prospective phase II study
por: Niu, Xiaoshuang, et al.
Publicado: (2023)

Concurrent Chemotherapy for T4 Classification Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy
por: Cao, Cai-neng, et al.
Publicado: (2015)

Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy
por: Wang, Jiazhou, et al.
Publicado: (2019)

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
por: Tasaka, Shun, et al.
Publicado: (2021)

Clinical outcome of intensity modulated radiotherapy for carcinoma showing thymus-like differentiation
por: Kong, Fangfang, et al.
Publicado: (2016)

Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
por: Chang, Hui, et al.
Publicado: (2018)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
por: Li, Qian, et al.
Publicado: (2021)

Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases
por: Ou, Xiaomin, et al.
Publicado: (2017)

Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy
por: Le, Ziyu, et al.
Publicado: (2017)

The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis
por: Liu, Fang, et al.
Publicado: (2018)

Induction Chemotherapy Combined With Intensity-Modulated Radiotherapy for 129 Nasopharyngeal Carcinoma Patients With Synchronous Metastases: A Retrospective Study
por: Ni, Mengshan, et al.
Publicado: (2021)

Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma
por: Luo, Yangkun, et al.
Publicado: (2016)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases
por: Zhang, Yuan, et al.
Publicado: (2016)

Prognostic value of hepatitis B viral infection in patients with nasopharyngeal carcinoma in the intensity-modulated radiotherapy era
por: Zheng, Shuo-Han, et al.
Publicado: (2021)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
por: He, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fjecqg5rd5h77eel4r2siaj6p5